Overview of commonly used animal models for chemotherapy-induced mucositisAnimalCytotoxic RegimensTypical Outcome MeasuresReferencesRats with or without cancerMice with or without cancerMTX 5-FU Ara-C cyclophosphamide melphalan doxorubicin irinotecan irradiation single doserepeated ip sc im or ivMTX 5-FU Ara-C melphalan doxorubicin vincristine carboplatin cyclophosphamide irradiation single doserepeated ip or imDiarrhea weight loss intestinal digestion absorption bacterial translocation histology inflammation apoptosis proliferation hematologyDiarrhea weight loss intestinal digestion absorption bacterial translocation histology inflammation oral mucositis for irradiation models23 27 59 6712430 35 51 124146 212Hamsters without cancer5-FU irradiation single doserepeated ip or imOral mucosal ulceration inflammation growthfactors26 37 117124 174Pigs without cancer5-FU doxorubicin cyclophosphamidebusulfan irradiation single doserepeated sc or ivClinical symptoms vomiting diarrhea weight loss digestion absorption intestinal histology permeability inflammation oral mucosal lesions107 128 130150 167202Dogs cats rabbits with or without cancerCisplatin irradiation single doserepeated ip sc im or ivNausea vomiting gastric mucosal injury oxidative stress liver damage13 75 129219Ara-C cytosine arabinoside 5-FU 5-fluorouracil MTX methotrexate im intramuscular ip intraperitoneal iv intravenous sc subcutaneous.G234ANIMAL MODELS OF CHEMOTHERAPY-INDUCED MUCOSITISvariable degrees of pain similar to the condition in human patients subjected to chemotherapy.

CIM may be subdivided into oral mucositis OM and intestinal mucositis IM two closely interacting clinical diagnoses.

Transforming growth factor-alpha stimulates enterocyte proliferation and accelerates intestinal recovery following methotrexate-induced intestinal mucositis in a rat and a cell culture model.

Experimental GIT- and nutrition-related interventions in animal models of chemotherapy-induced mucositisInterventionSubjectsFindingsConclusionReferencesElemental nutrientsRats catsDiarrhea and vomiting1 bacteriatranslocation2 villous blunting1 survival2Detrimental15 129Whey extracts TGF-f3 glutamine caseinRats hamstersGIT growth1 body weight1 sucraseactivity1 GIT permeability2 glutathione1Beneficial23 37 85195LactoferrinRats hamstersProliferation21 intestinal surface1 GIT permeability2Protectivedetrimental38 201ulceration2 diarrhea2ProbioticsRatsDigestive function1 permeability2 apoptosis2 weight loss2Prevents intestinal barrier disruption moderate benefits175 204 210PrebioticsRatsGIT mass1 villus and crypt1Beneficial216TGF-f3 arginine leptinRats miceMucosal weight1 GIT injury2 villus andcrypt1 proliferation2Protective beforeduring chemotherapy17 80 118201TGF-01RatsProliferation1 histological status1Improves healing186GLP-1 GLP-2Rats miceEpithelial injury2 intestinal repair1 mucosal mass1 sepsis2Protective against injury25 102 103189Multivitamins riboflavin folateRatsOxidative stress2 apoptosis2Attenuates GIT injury22Antioxidants grape seedsRatsCrypt depth1 histological status1inflammation2Prevents GIT damage33GIT gastrointestinal tract GLP glucagon-like peptide PUFA polyunsaturated fatty acids SCFA short-chain fatty acids TGF transforming growth factor1 increase 2 decrease.ANIMAL MODELS OF CHEMOTHERAPY-INDUCED MUCOSITISG239identify new treatment strategies for CIM based on preclinical models.The GIT is the focus of CIM toxicity and nutritional interventions and modulations of the gut microbiota are there- fore important among the potential management options.

First published October 26 2017 doi10.1152ajpgi.00204.2017.THEME Translational PhysiologyAnimal models of chemotherapy-induced mucositis translational relevance and challengesPer T. Sangild123 Rene Liang Shen1 Peter Pontoppidan12 and Mathias Rathe31Comparative Pediatrics and Nutrition University of Copenhagen Frederiksberg Denmark 2Department of Pediatrics and Adolescent Medicine Rigshospitalet Copenhagen Denmark and 3Hans Christian Andersen Children's Hospital Odense University Hospital Odense DenmarkSubmitted 28 June 2017 accepted in final form 12 October 2017Sangild PT Shen RL Pontoppidan P Rathe M. Animal models of chemo- therapy-induced mucositis translational relevance and challenges.

In synergy animal models of CIM provide the basic physiological understanding and the new ideas for treatment that are required to make competent decisions in clinical practice.chemotherapy inflammation intestine mice mucositis pig rat toxicityCLINICAL CONSEQUENCES OF CHEMOTHERAPY-INDUCED MUCOSITIS AND THE POTENTIAL OF ANIMAL MODELChemotherapy and radiation therapy may induce mucositis a common adverse effect of antineoplastic treatment that has severe consequences for the morbidity and mortality of cancer patients 36 49 172.

Animal studies may help to validate the initial reports that combined plasma citrulline I-FABP and I-BABP levels can be used to evaluate CIM following myeloablative chemotherapy 45.Cytokines and inflammatory markers play key roles in thepathogenesis of mucositis and elevated serum levels of proin- flammatory cytokines such as TNF IL-1f3 and IL-6 and acute phase reactants such as CRP are markers of the inflammatory response induced by various chemotherapeutic agents but can- not be considered specific for mucositis 65 111.

Annu Rev Anim Biosci 3 219 -244 2015. doi.Scully C Epstein J Sonis S. Oral mucositis a challenging complication of radiotherapy chemotherapy and radiochemotherapy part 1 patho- genesis and prophylaxis of mucositis.

Beneficial effects of cathepsin inhibition to prevent chemotherapy- induced intestinal mucositis.

Nutrition 28 572-580 2012. doi.Boukhettala N Ibrahim A Aziz M Vuichoud J Saudan KY Blum S Dechelotte P Breuille D Coeffier M. A diet containing whey protein free glutamine and transforming growth factor-f3 ameliorates nutritional outcome and intestinal mucositis during repeated chemother- apeutic challenges in rats.

